Over-The-Counter (OTC) Pet Medication Market Report 2026

Over-The-Counter (OTC) Pet Medication Market Overview

• Over-The-Counter (OTC) Pet Medication market size has reached to $9.15 billion in 2025 • Expected to grow to $12.16 billion in 2030 at a compound annual growth rate (CAGR) of 5.9% • Growth Driver: Rising Pet Ownership And Its Impact On The Growth Of The Over-The-Counter (OTC) Pet Medication Market • Market Trend: Zoetis Launches Innovative Food And Drug Administration (FDA) Approved Medications For Dogs • North America was the largest region in 2025.

What Is Covered Under Over-The-Counter (OTC) Pet Medication Market?

Over-the-counter (OTC) pet medication refers to medications and treatments for pets that can be purchased without a prescription from a veterinarian. These medications are typically available in retail stores, online, or through pet supply outlets. Over-the-counter (OTC) pet medications are intended for common health issues and preventive care for pets, such as flea and tick treatments, dental care products, supplements, and minor skin treatments. The main medication types of over-the-counter (OTC) pet medication are flea and tick control, wormers and dewormers, dental care, nutritional supplements, skin and coat care, pain and allergy relief, and other medications. Flea and tick control products help to prevent and eliminate infestations of fleas and ticks on pets. These products can include topical treatments, collars, sprays, and oral medications that protect pets from these common parasites. The various pets include dogs, cats, birds, fishes and reptiles, and other pets and various forms include chews and treats, capsules and ointment, sprays, and other forms and supplied through various distribution channels such as drug and pharmacy stores, pet specialty stores, veterinary clinics and hospitals, online retailers, and other distribution channels.

What Is The Over-The-Counter (OTC) Pet Medication Market Growth Forecast?

The over-the-counter (otc) pet medication market size is expected to see strong growth in the next few years. It will grow to $12.16 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to expansion of e-commerce for pet medications, increasing demand for preventive care products, growth in tech-enabled pet health monitoring, rising consumer spending on pet wellness, adoption of personalized supplements and treatments. Major trends in the forecast period include rising adoption of otc pet medications, integration of smart pet health devices, increasing awareness about preventive pet care, expansion of online pet pharmacies, growth in personalized pet nutrition and supplements.

Global Over-The-Counter (OTC) Pet Medication Market Segmentation

1) By Medication: Flea And Tick Control, Wormers And Dewormers, Dental Care, Nutritional Supplements, Skin And Coat Care, Pain And Allergy Relief, Other Medications 2) By Pet: Dogs, Cats, Birds, Fishes And Reptiles, Other Pets 3) By Form: Chews And Treats, Capsule And Ointment, Sprays, Other Forms 4) By Distribution Channel: Drug And Pharmacy Stores, Pet Specialty Stores, Veterinary Clinics And Hospitals, Online Retailers, Other Distribution Channels Subsegments: 1) By Flea And Tick Control: Topical Treatments, Oral Medications, Shampoos And Sprays 2) By Wormers And Dewormers: Oral Wormers, Topical Dewormers, Injectable Dewormers 3) By Dental Care: Toothpaste And Toothbrushes, Dental Chews And Treats, Oral Rinses And Sprays 4) By Nutritional Supplements: Vitamins And Minerals, Joint Health Supplements, Digestive Health Supplements, Immune Support Supplements 5) By Skin And Coat Care: Shampoos And Conditioners, Topical Creams And Sprays, Flea And Tick Sprays 6) By Pain And Allergy Relief: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Antihistamines, Steroid Creams And Ointments 7) By Other Medications: Digestive Aids, Anti-Anxiety Medications, Eye And Ear Care Products

What Is The Driver Of The Over-The-Counter (OTC) Pet Medication Market?

The rising pet ownership is expected to propel the growth of the over-the-counter (OTC) pet medication market going forward. Pet ownership refers to the legal and ethical responsibility of caring for and controlling a domesticated animal as a companion. The rising pet ownership is due to companionship and emotional support, improved living standards, urbanization, changing family structures, and increased awareness of the benefits of pet ownership for health and well-being. Over-the-counter (OTC) pet medications provide several benefits for pet owners, making caring for their pets more accessible and convenient. Over-the-counter (OTC) pet medications are easily accessible and reasonably priced, encouraging proper pet care by offering quick fixes for common health issues. For instance, in March 2024, according to UK Pet Food, a UK-based principal trade association, in 2024, an estimated 17.2 million households, representing 60% of UK homes, owned one or more of the nation’s 36 million pets. Therefore, rising pet ownership drives the over-the-counter (OTC) pet medication industry.

Key Players In The Global Over-The-Counter (OTC) Pet Medication Market

Major companies operating in the over-the-counter (otc) pet medication market are Zoetis Inc, Elanco Animal Health Incorporated, Virbac S A, PetIQ Holdings LLC, Vetoquinol S A, Bimeda Inc, Med‑Vet International Inc, Sergeant’s Pet Care Products Inc, Advecta, Zesty Paws, Durvet Inc, Pet King Brands, Animax Ltd, PetArmor, Dechra Pharmaceuticals, Beaphar, Innovacyn, Nutramax Laboratories, Vet’s Best, Vetriscience Laboratories, TropiClean, Hartz Mountain Corporation, Pet Honesty, Nutri‑Vet, NaturVet, Pet Naturals of Vermont, Grizzly Pet Products

Global Over-The-Counter (OTC) Pet Medication Market Trends and Insights

Major companies operating in the over-the-counter (OTC) pet medication market are concentrating on developing innovative products, such as the first monoclonal antibody, to sustain their position in the market. A monoclonal antibody is a type of antibody that is produced by identical immune cells that are all clones of a unique parent cell. For instance, in October 2023, Zoetis Inc., a US-based pharmaceutical company, launched Bedinvetmab injection and Oclacitinib chewable tablets approved by the Food and Drug Administration (FDA), a US-based federal agency. Oclacitinib chewable tablets gained FDA approval for controlling pruritus associated with allergic dermatitis and atopic dermatitis in dogs aged one year or older, presenting the first chewable treatment for allergic itch and inflammation in United States (US) canines. These veterinary medications are now accessible for prescription by veterinarians in the United States (US).

What Are Latest Mergers And Acquisitions In The Over-The-Counter (OTC) Pet Medication Market?

In April 2023, PetMed Express Inc., a US-based online pharmacy company, acquired PetCareRx Inc. for an undisclosed amount. With this acquisition, PetMeds aims to bolster its online pet pharmacy market position through expanded product offerings, a broader customer base, and enhanced operational integration and customer relationships. PetCareRx Inc. is a US-based pet health and wellness company offering a variety of over-the-counter (OTC) pet medications.

Regional Outlook

North America was the largest region in the over-the-counter (OTC) pet medication market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Over-The-Counter (OTC) Pet Medication Market?

The over-the-counter (OTC) pet medication market consists of sales of heartworm preventatives, digestive aids and probiotics, allergy relief medications, and worming medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Over-The-Counter (OTC) Pet Medication Market Report 2026?

The over-the-counter (otc) pet medication market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter (otc) pet medication industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.